Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Clinical Research and Equipment Industry Analysis

UpdatedMay 31, 2025
DataAggregated Company Financials
Companies7
  • 7D1.9%
  • 3M-1.5%
  • 1Y2.5%
  • YTDn/a

In the last week, Clinical Research and Equipment has been flat. Furthermore, the industry has been flat for the past year as well. Earnings are forecast to grow by 20% annually.

Industry Valuation and Performance

Has the Swiss Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 31 May 2025CHF 52.8bCHF 10.1bCHF 1.0b31.5x50.9x5.2x
Mon, 28 Apr 2025CHF 52.4bCHF 10.1bCHF 1.0b29.7x50.5x5.2x
Wed, 26 Mar 2025CHF 53.9bCHF 10.1bCHF 1.0b33.2x52.9x5.4x
Fri, 21 Feb 2025CHF 56.1bCHF 10.1bCHF 1.0b32.6x54.1x5.6x
Sun, 19 Jan 2025CHF 54.0bCHF 10.2bCHF 943.4m34.9x57.3x5.3x
Tue, 17 Dec 2024CHF 53.8bCHF 10.2bCHF 943.4m37.5x57x5.3x
Thu, 14 Nov 2024CHF 56.4bCHF 10.2bCHF 943.5m43.5x59.8x5.5x
Sat, 12 Oct 2024CHF 54.1bCHF 10.2bCHF 943.5m41.4x57.4x5.3x
Mon, 09 Sep 2024CHF 55.6bCHF 10.2bCHF 937.2m43x59.3x5.4x
Wed, 07 Aug 2024CHF 56.2bCHF 10.2bCHF 924.6m43.6x60.8x5.5x
Fri, 05 Jul 2024CHF 53.8bCHF 10.3bCHF 1.0b46.1x53.7x5.2x
Sun, 02 Jun 2024CHF 52.2bCHF 10.3bCHF 1.0b43.9x52.1x5.1x
Tue, 30 Apr 2024CHF 54.8bCHF 10.3bCHF 1.0b44.1x54.8x5.3x
Thu, 28 Mar 2024CHF 57.8bCHF 10.3bCHF 1.0b46.1x57.7x5.6x
Sat, 24 Feb 2024CHF 50.6bCHF 10.2bCHF 982.3m47.1x51.5x5x
Mon, 22 Jan 2024CHF 41.2bCHF 9.8bCHF 1.5b30.8x27.6x4.2x
Wed, 20 Dec 2023CHF 41.3bCHF 9.8bCHF 1.5b32.2x27.7x4.2x
Fri, 17 Nov 2023CHF 41.0bCHF 9.8bCHF 1.5b28.8x27.5x4.2x
Sun, 15 Oct 2023CHF 45.6bCHF 9.8bCHF 1.5b30.4x30.5x4.7x
Tue, 12 Sep 2023CHF 52.1bCHF 9.8bCHF 1.5b35.4x34.9x5.3x
Thu, 10 Aug 2023CHF 52.6bCHF 9.8bCHF 1.5b35.6x34x5.4x
Sat, 08 Jul 2023CHF 54.6bCHF 9.7bCHF 1.6b35.7x33.4x5.6x
Mon, 05 Jun 2023CHF 61.1bCHF 9.7bCHF 1.6b37.2x37.4x6.3x
Wed, 03 May 2023CHF 58.9bCHF 9.7bCHF 1.6b40.4x36x6.1x
Fri, 31 Mar 2023CHF 57.6bCHF 9.7bCHF 1.7b42.2x34.5x5.9x
Sun, 26 Feb 2023CHF 58.9bCHF 9.6bCHF 1.7b34.6x35.4x6.2x
Tue, 24 Jan 2023CHF 53.3bCHF 9.2bCHF 1.3b40.4x40.1x5.8x
Thu, 22 Dec 2022CHF 49.8bCHF 9.2bCHF 1.3b36.8x37.5x5.4x
Sat, 19 Nov 2022CHF 53.3bCHF 9.2bCHF 1.3b40.4x40.1x5.8x
Mon, 17 Oct 2022CHF 51.3bCHF 9.2bCHF 1.3b40.4x38.6x5.6x
Wed, 14 Sep 2022CHF 54.7bCHF 9.2bCHF 1.3b43.4x42.3x6x
Fri, 12 Aug 2022CHF 58.7bCHF 8.9bCHF 1.3b37x44.8x6.6x
Sun, 10 Jul 2022CHF 58.1bCHF 8.5bCHF 1.1b45.1x53.9x6.9x
Tue, 07 Jun 2022CHF 57.9bCHF 8.5bCHF 1.1b48.1x53.6x6.8x
Price to Earnings Ratio

53.6x


Total Market Cap: CHF 57.9bTotal Earnings: CHF 1.1bTotal Revenue: CHF 8.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Clinical Research and Equipment Industry Price to Earnings3Y Average 44.8x202320242025
Current Industry PE
  • Investors are optimistic on the Swiss Life Sciences Tools and Services industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 50.3x which is higher than its 3-year average PE of 44.8x.
  • The industry is trading close to its 3-year average PS ratio of 5.4x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 5.9% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Comparison

How does Swiss Clinical Research and Equipment compare with similar industries?

CH Market0.54%
Healthcare1.84%
Life Sciences1.91%
Clinical Research and Equipment1.91%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
LONN Lonza GroupCHF 569.201.6%
+CHF 649.9m		17.0%PE63.2x
BANB Bachem HoldingCHF 51.655.6%
+CHF 204.7m		-36.1%PE32.2x
PPGN PolyPeptide GroupCHF 21.3512.3%
+CHF 76.9m		-36.1%PS2.2x
SFZN Siegfried HoldingCHF 96.601.0%
+CHF 43.8m		7.5%PE26.4x
SKAN SKAN GroupCHF 71.902.6%
+CHF 40.5m		-10.7%PE41.7x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

TECN

CHF 163.70

Tecan Group

7D

-1.1%

1Y

-48.7%

At CHF170, Is Tecan Group AG (VTX:TECN) Worth Looking At Closely?

May 28
At CHF170, Is Tecan Group AG (VTX:TECN) Worth Looking At Closely?

SKAN

CHF 71.90

SKAN Group

7D

2.6%

1Y

-10.7%

PPGN

CHF 21.35

PolyPeptide Group

7D

12.3%

1Y

-36.1%

Does PolyPeptide Group (VTX:PPGN) Have A Healthy Balance Sheet?

May 23
Does PolyPeptide Group (VTX:PPGN) Have A Healthy Balance Sheet?

BANB

CHF 51.65

Bachem Holding

7D

5.6%

1Y

-36.1%

Bachem Holding AG's (VTX:BANB) Share Price Matching Investor Opinion

May 15
Bachem Holding AG's (VTX:BANB) Share Price Matching Investor Opinion

XLS

CHF 19.85

Xlife Sciences

7D

-1.7%

1Y

-39.8%

LONN

CHF 569.20

Lonza Group

7D

1.6%

1Y

17.0%

SFZN

CHF 96.60

Siegfried Holding

7D

1.0%

1Y

7.5%